The role of ALBI score in patients treated with stereotactic body radiotherapy for locally advanced primary liver tumors: a pooled analysis of two prospective studies
SBRT is a very effective treatment with low toxicity and should be considered as a local treatment option in patients with HCC and CCC. Patients with a higher ALBI grade are at risk for developing toxicities after SBRT and have a significantly lower survival rate.
Authors
- Alexandra Eichhorst
- Eleni Gkika (ORCID: https://orcid.org/0000-0001-5455-252X)
- Simon Kirste (ORCID: https://orcid.org/0000-0001-5556-6069)
- R. Wiehle
- Thomas Brunner (ORCID: https://orcid.org/0000-0002-1594-4712)
- Gianluca Radicioni (ORCID: https://orcid.org/0000-0002-0215-3321)
- Anca-Ligia Grosu (ORCID: https://orcid.org/0000-0003-2255-2255)
- Robert Thimme (ORCID: https://orcid.org/0000-0003-1417-4135)
- Stefan Fichtner‐Feigl (ORCID: https://orcid.org/0000-0002-6710-562X)
- Tanja Sprave (ORCID: https://orcid.org/0000-0003-1292-1352)
- Nils H. Nicolay (ORCID: https://orcid.org/0000-0003-2550-1410)
Institutions
- University of Bonn (DE)
- University of Freiburg (DE)
- German Cancer Research Center (DE)
- Medical University of Graz (AT)
- University Hospital Bonn (DE)
- University Medical Center Freiburg (DE)
- University Hospital Leipzig (DE)
- Deutsches Konsortium für Translationale Krebsforschung (DE)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-03
- DOI
- https://doi.org/10.3389/fonc.2024.1427332
- Citations
- 4
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.48